Hepatic venous pressure gradient measurement in clinical hepatology

Digestive and Liver Disease

Volumn 43, Issue 10, 2011, Pages 762-767

  Merkel, Carlo ^a   Montagnese, Sara ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Beta blockers; Cirrhosis; Hepatic venous pressure gradient; Portal hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

BLEEDING; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; HEALTH CARE COST; HEPATIC VENOUS PRESSURE; HUMAN; LIVER FUNCTION; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; VENOUS PRESSURE;

BLOOD PRESSURE DETERMINATION; HEPATIC VEINS; HUMANS; HYPERTENSION, PORTAL; PRACTICE GUIDELINES AS TOPIC;

EID: 80052448303     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.03.002     Document Type: Review

References (61)

1. Myers J., Taylor W. An estimation of portal venous pressure by occlusive catheterization of a hepatic venule. J Clin Invest 1951, 30:662-663.
2. Thalheimer U., Leandro G., Samonakis D.N., et al. Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients. Dig Liver Dis 2005, 37:601-608.
3. La Mura V., Abraldes J.G., Berzigotti A., et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology 2010, 51:2108-2116.
4. Viallet A., Joly J.G., Marleau D., et al. Comparison of free portal venous pressure and wedged hepatic venous pressure in patients with cirrhosis of the liver. Gastroenterology 1970, 59:372-375.
5. Boyer T.D., Triger D.R., Horisawa M., et al. Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology 1977, 72:584-589.
6. Perello A., Escorsell A., Bru C., et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology 1999, 30:1393-1397.
7. Reynolds T.B., Ito S., Iwatsuki S. Measurement of portal pressure and its clinical application. Am J Med 1970, 49:649-657.
8. Groszmann R.J., Glickman M., Blei A.T., et al. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology 1979, 76:253-258.
9. Bützow G.H., Novak D. Clinical value of hepatic vein catheterization. Improved praticability by balloon catheter technique. Gastrointest Radiol 1977, 2:153-161.
10. Koyama K., Ito K., Asanuma Y., et al. Hepatic venography in portal hypertension by balloon catheter. Tohoku J Exp Med 1983, 139:349-354.
11. Zipprich A., Winkler M., Seufferlein T., et al. Comparison of balloon vs. straight catheter for the measurement of portal hypertension. Aliment Pharmacol Ther 2010, 32:1351-1356.
12. Montagnese S., Cavasin L., Vezzaro R., et al. Variability of the hepatic venous pressure gradient (HVPG) within the cirrhotic liver: an issue or a technical issue?. Hepatology 2009, 50(Suppl. 1):444A.
13. Garcia-Tsao G., Groszmann R.J., Fisher R.L., et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985, 5:419-424.
14. Groszmann R.J., Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology 2004, 39:280-282.
15. Bosch J., Garcia-Pagan J.C., Berzigotti A., et al. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis 2006, 26:348-362.
16. Amoros A., Palazon J.M., Zapater P., et al. A cost-effectiveness study of hepatic venous pressure gradient measurement in the secondary prevention of variceal bleeding. Rev Esp Enferm Dig 2008, 100:416-422.
17. Targownik L.E., Spiegel B.M., Dulai G.S., et al. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am J Gastroenterol 2004, 99:1306-1315.
18. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000, 33:846-852.
19. Zuin R., Gatta A., Merkel C., et al. Evaluation of peritoneoscopic and oesophagoscopic findings as indexes of portal hypertension in patients with liver cirrhosis. Italian J Gastroenterol 1982, 14:214-219.
20. Gluud C., Henriksen J.H., Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology 1988, 8:222-227.
21. Merkel C., Bolognesi M., Bellon S., et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992, 102:973-979.
22. Vinel J.P., Cassigneul J., Louis A., et al. Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis. Surg Gynecol Obstet 1982, 155:347-352.
23. Vinel J.P., Cassigneul J., Levade M., et al. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology 1986, 6:116-117.
24. Merkel C., Bolognesi M., Angeli P., et al. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding. Am J Gastroenterol 1989, 84:717-722.
25. Patch D., Armonis A., Sabin C., et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut 1999, 44:264-269.
26. Ripoll C., Banares R., Rincon D., et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology 2005, 42:793-801.
27. Ripoll C., Groszmann R., Garcia-Tsao G., et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007, 133:481-488.
28. Ripoll C. Hepatic venous pressure gradient and outcomes in cirrhosis. J Clin Gastroenterol 2007, 41(Suppl. 3):S330-S335.
29. Serste T., Bourgeois N., Lebrec D., et al. Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis. Acta Gastroenterol Belg 2006, 69:355-360.
30. Menchen L., Ripoll C., Marin-Jimenez I., et al. Prevalence of portal hypertensive duodenopathy in cirrhosis: clinical and haemodynamic features. Eur J Gastroenterol Hepatol 2006, 18:649-653.
31. Moitinho E., Escorsell A., Bandi J.C., et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999, 117:626-631.
32. Groszmann R.J., Garcia-Tsao G., Bosch J., et al. Portal hypertension collaborative group beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005, 353:2254-2261.
33. Ripoll C., Groszmann R.J., Garcia-Tsao G., et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009, 50:923-928.
34. Blasco A., Forns X., Carrion J.A., et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006, 43:492-499.
35. Armonis A., Patch D., Burroughs A. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?. Hepatology 1997, 25:245-248.
36. Bosch J., Berzigotti A., Garcia-Pagan J.C., et al. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008, 48(Suppl. 1):S68-S92.
37. Triantos C.K., Nikolopoulou V., Burroughs A.K. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis. Aliment Pharmacol Ther 2008, 28:943-952.
38. Groszmann R.J., Bosch J., Grace N.D., et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990, 99:1401-1407.
39. Sacerdoti D., Merkel C., Gatta A. Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis. J Hepatol 1991, 12:124-125.
40. Feu F., Garcia-Pagan J.C., Bosch J., et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995, 346:1056-1059.
41. D'Amico G., Garcia-Pagan J.C., Luca A., et al. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006, 131:1611-1624.
42. Albillos A., Banares R., Gonzalez M., et al. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol 2007, 102:1116-1126.
43. Merkel C., Bolognesi M., Sacerdoti D., et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000, 32:930-934.
44. Villanueva C., Minana J., Ortiz J., et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001, 345:647-655.
45. Turnes J., Garcia-Pagan J.C., Abraldes J.G., et al. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis. Am J Gastroenterol 2006, 101:506-512.
46. Villanueva C., Aracil C., Colomo A., et al. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology 2009, 137:119-128.
47. Merkel C., Sacerdoti D., Bolognesi M., et al. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment. J Hepatol 1998, 28:622-630.
48. Sabbá C., Merkel C., Zoli M., et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995, 21:428-433.
49. La Mura V., Abraldes J.G., Raffa S., et al. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension. J Hepatol 2009, 51:279-287.
50. Bureau C., Peron J.M., Alric L., et al. A La Carte treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002, 36:1361-1366.
51. Dell'Era A., Sotela J.C., Fabris F.M., et al. Primary prophylaxis of variceal bleeding in cirrhotic patients: a cohort study. Dig Liver Dis 2008, 40:936-943.
52. Villanueva C., Lopez-Balaguer J.M., Aracil C., et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 2004, 40:757-765.
53. Merkel C., Bolognesi M., Berzigotti A., et al. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol 2010, 52:45-53.
54. Monescillo A., Martinez-Lagares F., Ruiz-del-Arbol L., et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004, 40:793-801.
55. Rossle M., Siegerstetter V., Olschewski M., et al. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 2001, 96:3379-3383.
56. Boyer T.D., Haskal Z.J. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 2005, 16:615-629.
57. Boyer T.D., Haskal Z.J. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology 2010, 51:306.
58. An M., Park J.W., Shin J.A., et al. The adverse effect of indirectly diagnosed portal hypertension on the complications and prognosis after hepatic resection of hepatocellular carcinoma. Korean J Hepatol 2006, 12:553-561.
59. Bruix J., Castells A., Bosch J., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996, 111:1018-1022.
60. Kanematsu T., Furui J., Yanaga K., et al. Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma. Hepatogastroenterology 2005, 52:1828-1831.
61. Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30:1434-1440.